Köckerling Ferdinand, Alam Nasra N, Narang Sunil K, Daniels Ian R, Smart Neil J
Department of Surgery and Center for Minimally Invasive Surgery, Academic Teaching Hospital of Charité Medical School, Vivantes Hospital , Berlin , Germany.
Exeter Surgical Health Services Research Unit (HeSRU), Royal and Exeter Hospital , Exeter , UK.
Front Surg. 2015 Oct 16;2:55. doi: 10.3389/fsurg.2015.00055. eCollection 2015.
In a recent Cochrane review, the authors concluded that there is an urgent need for well-powered, well-conducted randomized controlled trials comparing various modes of treatment of fistula-in-ano. Ten randomized controlled trials were available for analyses: There were no significant differences in recurrence rates or incontinence rates in any of the studied comparisons. The following article reviews the studies available for treatment of fistula-in-ano with a fistula plug with special attention paid to the technique.
PubMed, Medline, Embase, and the Cochrane medical database were searched up to July 2015. Sixty-four articles were relevant for this review.
Healing rates of 50-60% can be expected for treatment of complex anal fistula with a fistula plug, with a plug-extrusion rate of 10-20%. Such results can be achieved not only with plugs made of porcine intestinal submucosa but also those made of other biological or synthetic bioabsorbable mesh materials. Important technical steps are firm suturing of the head of the plug in the primary opening and wide drainage of the secondary opening.
Treatment of a complex fistula-in-ano with a fistula plug is an option with a success rate of 50-60% with low complication rate. Further improvements in technique and better studies are needed.
在最近的一篇Cochrane综述中,作者得出结论,迫切需要开展样本量充足、实施良好的随机对照试验,以比较肛瘘的各种治疗方式。有10项随机对照试验可供分析:在任何一项研究比较中,复发率或失禁率均无显著差异。以下文章回顾了使用肛瘘塞治疗肛瘘的现有研究,并特别关注了相关技术。
检索截至2015年7月的PubMed、Medline、Embase和Cochrane医学数据库。64篇文章与本综述相关。
使用肛瘘塞治疗复杂性肛瘘的愈合率可达50%-60%,塞子挤出率为10%-20%。不仅使用猪小肠黏膜下层制成的塞子能取得这样的结果,使用其他生物或合成可生物吸收网状材料制成的塞子也能达到。重要的技术步骤包括将塞子头部牢固缝合在原发开口处,并对继发开口进行充分引流。
用肛瘘塞治疗复杂性肛瘘是一种选择,成功率为50%-60%,并发症发生率低。需要进一步改进技术并开展更好的研究。